V-Wave Ltd.

www.vwavemedical.com

Now Johnson & Johnson MedTech Israel

High-Tech Company

Acquired by Johnson & Johnson Inc.

TECH VERTICALS

Cardiac, Healthtech, Heart Failure, Implants, Life Sciences, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	R&D
Established	2009
Number of Employees	70
Employees in Israel	25
Reg. Number:	abCDe

DESCRIPTION

V-Wave is focused on developing percutaneous implantable devices for treating patients with chronic Heart Failure (HF). As a leading cause of death and hospitalization, HF continues to affect millions of people worldwide. V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave has developed a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.

TECHNOLOGY

The V-Wave® Ventura® Interatrial Shunt is a novel, hourglass-shaped implantable device. The shunt is designed to enable shunting of blood across the interatrial septum.

Products and Phases

Product	Phase
Ventura™ Interatrial Shunt System	Phase III CE Approved
The novel hourglass design of the Ventura® Interatrial Shunt is engineered to create a venturi tube-like effect from the high-pressure atrium to the low-pressure atrium. This effect increases the efficiency of blood transfer, permitting a smaller size shunt. The shunt is implanted across a patient’s interatrial septum using a right-sided femoral catheterization procedure.

	TARGET MARKETS
	Hospitals and Clinics, Patients suffering from heart problems.

	BUSINESS MODEL
	B2B

REMARKS

Date	Remark
15/08/2019	Received FDA Breakthrough Device Designation for Heart Failure (HF).

CONTACT INFO

Expand / Collapse All

Main Address: Caesarea, Israel

Address	15 Halamish St. Caesarea Industrial Park (North)
POB	3076
City	Caesarea
Country	Israel
Zip	3079827

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Agoura Hills, United States

Address	29229 Canwood St #100
City	Agoura Hills
State/Province	CA
Country	United States
Zip	91301

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Prof. Gad Keren	Co-Founder
Mr. Yaacov Nitzan	Co-Founder
Dr. Ascher Shmulewitz	Co-Founder	TopSpin Medical (CEO)

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Aug. 20, 2024

R&D

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Third Round - Extended

Sep. 22, 2020

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Secondary Fund	abCDe
abC Defghij	Investment Company	abCDe	Led the round
abC Defghij	Investment Company	abCDe

Third Round

Apr. 26, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe
abC Defghij	Secondary Fund	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Investment Company	abCDe	Led the round
abC Defghij	Investment Company	abCDe
abC Defghij	High-Tech Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

Second Round

Jan. 12, 2016

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe	Led the round
abC Defghij	Holding Company	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	High-Tech Company	abCDe

First Round

Jul. 02, 2013

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	High-Tech Company	abCDe

Seed - Extended

Jul. 23, 2012

Seed

abCDe

Seed

Oct. 01, 2010

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jun. 01, 2020

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

Last Updated:	abCDe
IVC Number:	abCDe